Centro de Estudos e Pesquisas em Hematologia e Oncologia

Santo André, São Paulo 09060-650

0 studies enrolling now · 1 studies all time

What they study most

Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment — Running, not enrolling